Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-15-037217
Filing Date
2015-06-15
Accepted
2015-06-15 16:31:13
Documents
14
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v412306_10k.htm 10-K 1455506
2 EXHIBIT 10.85 v412306_ex10-85.htm EX-10.85 111809
3 EXHIBIT 21 v412306_ex21.htm EX-21 1566
4 EXHIBIT 23 v412306_ex23.htm EX-23 3439
5 EXHIBIT 31.1 v412306_ex31-1.htm EX-31.1 9571
6 EXHIBIT 31.2 v412306_ex31-2.htm EX-31.2 9657
7 EXHIBIT 32.1 v412306_ex32-1.htm EX-32.1 4616
8 EXHIBIT 32.2 v412306_ex32-2.htm EX-32.2 4876
  Complete submission text file 0001144204-15-037217.txt   10843398

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT eltp-20150331.xml EX-101.INS 1613471
10 XBRL TAXONOMY EXTENSION SCHEMA eltp-20150331.xsd EX-101.SCH 88149
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eltp-20150331_cal.xml EX-101.CAL 64509
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eltp-20150331_def.xml EX-101.DEF 434076
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE eltp-20150331_lab.xml EX-101.LAB 507742
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eltp-20150331_pre.xml EX-101.PRE 522860
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15697 | Film No.: 15931542
SIC: 2834 Pharmaceutical Preparations